Shanghai RAAS Blood Products Co Ltd Class A (002252) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.026x

Based on the latest financial reports, Shanghai RAAS Blood Products Co Ltd Class A (002252) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-843.75 Million ≈ $-123.47 Million USD) by net assets (CN¥32.46 Billion ≈ $4.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Shanghai RAAS Blood Products Co Ltd Clas worth for the company's overall valuation and market capitalisation.

Shanghai RAAS Blood Products Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Shanghai RAAS Blood Products Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai RAAS Blood Products Co Ltd Class A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai RAAS Blood Products Co Ltd Class A ranked by their cash flow conversion efficiency. Explore Shanghai RAAS Blood Products Co Ltd Clas cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Bechtle AG
XETRA:BC8
-0.057x
RTL Group SA
F:RRTL
-0.003x
Chartwell Retirement Residences
TO:CSH-UN
0.034x
Vietnam Dairy Products JSC
VN:VNM
0.050x
Zhejiang Sanmei Chemical Industry Co Ltd
SHG:603379
0.081x
FORM.DE C.Y C.ADR 1/5/EO1
F:FCC0
N/A
Gentex Corporation
NASDAQ:GNTX
0.073x
Allfunds Group Ltd
AS:ALLFG
0.264x

Annual Cash Flow Conversion Efficiency for Shanghai RAAS Blood Products Co Ltd Class A (2005–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai RAAS Blood Products Co Ltd Class A from 2005 to 2025. View 002252 stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥32.47 Billion
≈ $4.75 Billion
CN¥-104.89 Million
≈ $-15.35 Million
-0.003x +78.59%
2024-12-31 CN¥31.94 Billion
≈ $4.67 Billion
CN¥-482.06 Million
≈ $-70.54 Million
-0.015x -119.64%
2023-12-31 CN¥29.65 Billion
≈ $4.34 Billion
CN¥2.28 Billion
≈ $333.33 Million
0.077x +28.28%
2022-12-31 CN¥28.81 Billion
≈ $4.22 Billion
CN¥1.73 Billion
≈ $252.51 Million
0.060x +19.89%
2021-12-31 CN¥25.90 Billion
≈ $3.79 Billion
CN¥1.29 Billion
≈ $189.35 Million
0.050x +7.40%
2020-12-31 CN¥25.13 Billion
≈ $3.68 Billion
CN¥1.17 Billion
≈ $171.04 Million
0.047x -38.76%
2019-12-31 CN¥11.49 Billion
≈ $1.68 Billion
CN¥872.69 Million
≈ $127.70 Million
0.076x +215.35%
2018-12-31 CN¥10.90 Billion
≈ $1.60 Billion
CN¥262.50 Million
≈ $38.41 Million
0.024x +11.83%
2017-12-31 CN¥12.48 Billion
≈ $1.83 Billion
CN¥268.76 Million
≈ $39.33 Million
0.022x -60.42%
2016-12-31 CN¥11.73 Billion
≈ $1.72 Billion
CN¥638.22 Million
≈ $93.39 Million
0.054x -23.55%
2015-12-31 CN¥10.71 Billion
≈ $1.57 Billion
CN¥762.42 Million
≈ $111.57 Million
0.071x +31.73%
2014-12-31 CN¥8.62 Billion
≈ $1.26 Billion
CN¥465.96 Million
≈ $68.18 Million
0.054x +166.06%
2013-12-31 CN¥1.10 Billion
≈ $161.22 Million
CN¥-90.11 Million
≈ $-13.19 Million
-0.082x -131.65%
2012-12-31 CN¥1.02 Billion
≈ $149.18 Million
CN¥263.46 Million
≈ $38.55 Million
0.258x +34.61%
2011-12-31 CN¥927.27 Million
≈ $135.69 Million
CN¥178.03 Million
≈ $26.05 Million
0.192x -20.29%
2010-12-31 CN¥831.21 Million
≈ $121.63 Million
CN¥200.21 Million
≈ $29.30 Million
0.241x +58.49%
2009-12-31 CN¥763.33 Million
≈ $111.70 Million
CN¥116.01 Million
≈ $16.98 Million
0.152x +6.57%
2008-12-31 CN¥754.76 Million
≈ $110.45 Million
CN¥107.64 Million
≈ $15.75 Million
0.143x -86.20%
2007-12-31 CN¥170.01 Million
≈ $24.88 Million
CN¥175.71 Million
≈ $25.71 Million
1.034x +202.38%
2006-12-31 CN¥156.77 Million
≈ $22.94 Million
CN¥53.58 Million
≈ $7.84 Million
0.342x +46.61%
2005-12-31 CN¥231.70 Million
≈ $33.90 Million
CN¥54.02 Million
≈ $7.90 Million
0.233x --

About Shanghai RAAS Blood Products Co Ltd Class A

SHE:002252 China Biotechnology
Market Cap
$4.74 Billion
CN¥32.37 Billion CNY
Market Cap Rank
#3698 Global
#507 in China
Share Price
CN¥4.91
Change (1 day)
-0.81%
52-Week Range
CN¥4.31 - CN¥6.93
All Time High
CN¥24.72
About

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinoge… Read more